These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1967437)

  • 1. ABO incompatibility and platelet transfusion.
    Lancet; 1990 Jan; 335(8682):142-3. PubMed ID: 1967437
    [No Abstract]   [Full Text] [Related]  

  • 2. Pooled platelet concentrate.
    Roy RB
    CMAJ; 1988 Jun; 138(12):1089. PubMed ID: 3370590
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute intravascular hemolysis after a platelet transfusion.
    Ferguson DJ
    CMAJ; 1988 Mar; 138(6):523-4. PubMed ID: 3345477
    [No Abstract]   [Full Text] [Related]  

  • 4. [ABO blood groups and platelet transfusion].
    Eckstein R; Zeiler T; Zingsem J; Heuft HG; Musch R; Weisbach V
    Beitr Infusionsther; 1990; 26():157-9. PubMed ID: 1703819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 7. [ABO INCOMPATIBILITY. CAUSE OF A TRANSFUSION ACCIDENT?].
    LIPP R
    Bibl Haematol; 1964; 20():78-81. PubMed ID: 14237846
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M; Cid J
    Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 10. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological findings in alloimmune neonatal thrombocytopenia.
    Kakaiya RM; Cable RG; Pisciotto P; Morse EE; Silver H; Kranwinkel RN
    Conn Med; 1986 Apr; 50(4):220-4. PubMed ID: 3709173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent studies of the incidence of IgG allo-antibodies in blood transfusion recipients].
    Lynen R; Sindu E; Gallasch E; Neumeyer H
    Infusionstherapie; 1989 Dec; 16(6):273-5. PubMed ID: 2560466
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion of apheresis platelets and ABO groups.
    Vox Sang; 2005 Apr; 88(3):207-21. PubMed ID: 15787735
    [No Abstract]   [Full Text] [Related]  

  • 14. ABO blood group discrepancies among blood donors in Regional Blood Transfusion Centre GTB Hospital, Delhi, India.
    Sharma T; Garg N; Singh B
    Transfus Apher Sci; 2014 Feb; 50(1):75-80. PubMed ID: 24314713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolysis from platelet transfusion: call to action for an underreported reaction.
    Quillen K
    Transfusion; 2012 Oct; 52(10):2072-4. PubMed ID: 23110729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Root cause analysis of non-infectious transfusion complications and the lessons learnt.
    Karim F; Moiz B; Shamsuddin N; Naz S; Khurshid M
    Transfus Apher Sci; 2014 Feb; 50(1):111-7. PubMed ID: 24239270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombocyte transfusion. Indications, side effects and problems].
    Böck M; Heim MU; Salat C; Hiller E; Mempel W
    Fortschr Med; 1993 Jul; 111(19):332-4. PubMed ID: 8370563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune hemolytic anemia caused by antibodies of the ABO system following ABO-incompatible kidney transplantation. Gm allotyping of the immune antibody].
    Bein G; Poschmann A; Rob P
    Beitr Infusionsther; 1988; 21():251-4. PubMed ID: 2462986
    [No Abstract]   [Full Text] [Related]  

  • 20. ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants.
    Boctor FN; Bhaskaran M; Sheahan B; Heaton WA; Molmenti E
    Transfusion; 2011 Aug; 51(8):1874-5. PubMed ID: 21831188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.